Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-09-27 Management Reports
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management Discussion & Analysis' (MD&A) for the years ended June 30, 2021 and 2020, prepared in accordance with Canadian securities regulations (NI 51-102). It contains detailed financial and operational analysis, including business overview, financial review, liquidity, capital resources, accounting estimates, and risk factors. The document references the company's audited consolidated financial statements and is typical of a comprehensive management report accompanying annual financial results. The length (15,000 characters) and content indicate this is not a brief announcement or certification but a substantive report. Therefore, this document fits the category of Management Reports (MDA).
2021-09-27 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109F1 Certification of Annual Filings by the Chief Financial Officer of Aurora Cannabis Inc. It certifies the review and fair presentation of the annual filings including the annual financial statements and MD&A for the fiscal year ended June 30, 2021. The document focuses on the officer's attestation regarding disclosure controls and internal control over financial reporting (ICFR). It does not contain actual financial statements or substantive financial data but is a certification letter related to the annual filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) or other financial reports themselves.
2021-09-27 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109F1 Certification of Annual Filings by the CEO of Aurora Cannabis Inc. It certifies the review and fair presentation of the annual filings including the annual financial statements and annual MD&A for the financial year ended June 30, 2021. The document is primarily an officer certification attesting to the accuracy and completeness of the annual filings and the effectiveness of disclosure controls and internal controls over financial reporting. It does not contain the actual financial statements or substantive financial data itself, but rather certifies the annual filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report (10-K) or management reports (MDA). The document length is about 5,222 characters, which is consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-09-27 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to reporting issuers and participation fees, submitted to the Alberta Securities Commission. It includes a management certification by an officer (Chief Financial Officer) certifying the completeness and accuracy of the form. The content focuses on market values of securities, trading periods, and fee calculations. There are no financial statements, detailed financial performance data, or management discussion of results. The document is primarily a regulatory form with officer certification and fee calculation details, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance filing with certification rather than a full financial report or announcement.
2021-09-27 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1 related to participation fees for Class 1 and Class 3B reporting issuers, submitted to the Ontario Securities Commission. It includes management certification by an officer, market value calculations of equity securities for specified trading periods, and fee calculations based on capitalization. The content is regulatory in nature, focusing on fee reporting and certification rather than financial performance, earnings, or management discussion. It does not contain financial statements or detailed financial analysis. The presence of a management certification and fee calculation under a securities commission rule indicates this is a regulatory filing rather than an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-09-27 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Aurora Cannabis's financial and operational results for the fiscal 2021 fourth quarter and full year ended June 30, 2021. It includes comprehensive financial data such as net revenues, adjusted gross margins, EBITDA losses, cash flow statements, balance sheet details, and operational highlights. The presence of extensive financial metrics, period comparisons, and management commentary on business transformation and cost savings indicates this is a quarterly financial report. The document is about the fiscal Q4 2021 results, which fits the definition of an Interim / Quarterly Report (IR). It is not a brief earnings release (ER) since it contains detailed financial data and analysis, nor is it an announcement of a report publication (RPA) because it contains the actual financial results, not just a notice. Therefore, the correct classification is IR with high confidence. Q4 2021
2021-09-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.